RE: clarification
Kev... I understand definitively that SCIENTIFIC CLINICAL TRIAL RESULTS for 1402 will be released in the December issue of BLOOD MAGAZINE in Mid NOVEMBER, followed by an extensive presentation by Prometic at the ASH conference in December.
IMHO, Its almost hard to overstate how huge this publicity is going to be for Prometic and 1402 specifically. When you add this potential to all of the other imminent catalysts this company has, its easy to see why we are finally seeing a decent amount of sustained buying...and a revaluation. Exciting times for all of us.